Breaking News Instant updates and real-time market news.

TWX

Time Warner

$102.40

-0.09 (-0.09%)

, CMCSA

Comcast

$38.10

0.63 (1.68%)

17:10
09/24/17
09/24
17:10
09/24/17
17:10

Box Office Battle: 'Kingsman: The Golden Circle' easily wins weekend

"Kingsman: The Golden Circle" easily won the weekend in North America, grossing $39M from 4,003 theaters. While the sequel scored one of the best openings for the month of September, it came in somewhat behind expectations. Overseas, Kingsman 2 kicked off with $61M, for a global tally of $100M. The movie was distributed by 20th Century Fox (FOXA) and received a 51% rating on Rotten Tomatoes. BOX OFFICE RUNNERS-UP: New Line Cinema and Warner Bros. (TWX) horror movie "It" followed at number 2, with the movie's domestic cume standing at $266.3M. Behind it was Warner Bros.' animated family offering "The Lego Ninjago Movie," which launched to a meek $21.2M from 4,047 locations domestically. Lionsgate's (LGF.A) "American Assassin" followed at number four, with an estimated $6.2M in its second weekend for a domestic total of $26.2M. Rounding out the top five, the romantic comedy distributed by Open Road films "Home Again" earned an estimated $3.3M. Other publicly traded companies in filmmaking include Viacom (VIAB; VIA), Sony (SNE), Comcast (CMCSA), and Walt Disney (DIS).

TWX

Time Warner

$102.40

-0.09 (-0.09%)

CMCSA

Comcast

$38.10

0.63 (1.68%)

CMCSK

Comcast

SNE

Sony

$37.50

0.04 (0.11%)

FOX

21st Century Fox

$26.43

0.1 (0.38%)

FOXA

21st Century Fox

$26.88

0.12 (0.45%)

LGF.A

Lionsgate

$31.49

0.24 (0.77%)

DIS

Disney

$98.60

-0.29 (-0.29%)

VIAB

Viacom

$27.64

0.24 (0.88%)

VIA

Viacom

$38.00

-0.2 (-0.52%)

  • 27

    Sep

  • 22

    Oct

  • 26

    Oct

TWX Time Warner
$102.40

-0.09 (-0.09%)

09/18/17
FBCO
09/18/17
DOWNGRADE
FBCO
Time Warner downgraded to Neutral from Outperform at Credit Suisse
Credit Suisse analyst Omar Sheikh downgraded Time Warner (TWX) saying he expects the acquisition by AT&T (T) to be approved shortly and believes objections from Brazilian regulators likely to be surmountable.
08/07/17
EVER
08/07/17
DOWNGRADE
EVER
In Line
Time Warner downgraded to In Line from Outperform at Evercore ISI
Evercore ISI analyst Vijay Jayant dowgnraded Time Warner (TWX) to In Line saying shares are trading 5% below the $108 merger price with AT&T (T).
08/04/17
LEHM
08/04/17
DOWNGRADE
LEHM
Equal Weight
Time Warner downgraded to Equal Weight from Overweight at Barclays
08/03/17
JEFF
08/03/17
DOWNGRADE
Target $105
JEFF
Hold
Time Warner downgraded to Hold from Buy at Jefferies
Jefferies analyst John Janedis downgraded Time Warner (TWX) to Hold saying the AT&T (T) takeover appears on track to close in Q4. The analyst keeps a $105 price target for the shares.
CMCSA Comcast
$38.10

0.63 (1.68%)

09/12/17
09/12/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Comerica (CMA) upgraded to Overweight from Neutral at Piper Jaffray with analyst Brett Rabatin saying the bank's mid-quarter update is better than expected. 2. Alcoa (AA) upgraded to Buy from Hold at Deutsche Bank with analyst Jorge Beristain basing the upgrade on the firm's commodity team raising its 2018 aluminum price forecast by 12% to $2,072 per ton. 3. Kroger (KR) upgraded to Buy from Hold at Pivotal Research with analyst Ajay Jain saying continued weakness in investor sentiment following Kroger's latest results presents a near-term buying opportunity. 4. Comcast (CMCSA) upgraded to Buy from Neutral at MoffettNathanson with analyst Craig Moffett saying Comcast shares cheap following management comments on third quarter subscriber loses and the resulting stock selloff is overdone. 5. Inovalon (INOV) upgraded to Equal Weight from Underweight at Morgan Stanley with analyst Ricky Goldwasser saying that the company's presentation at the firm's healthcare conference provided a line of sight to organic earnings acceleration in the second half of the year. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/11/17
TDSI
09/11/17
NO CHANGE
Target $51
TDSI
Buy
Comcast shares oversold, says TD Securities
TD Securities analyst Vince Valentini believes the market has "materially" overreacted to management comments that it expects Comcast to lose 100k to 150k residential video subscribers in Q3. Valentini said the market-cap erosion since the comments on Wednesday has been approximately $14B, implying each video subscriber value is over $90k, which is extreme. The analyst believes this makes no sense and views the weakness in Comcast shares as "oversold" and reiterates his Buy rating and $51 price target.
09/12/17
MOFT
09/12/17
UPGRADE
MOFT
Buy
Comcast upgraded to Buy from Neutral at MoffettNathanson
09/12/17
09/12/17
UPGRADE

Buy
Comcast upgraded to Buy on valuation at MoffettNathanson
As previously reported, MoffettNathanson upgraded Comcast to Buy from Neutral with a $45 price target. Analyst Craig Moffett said Comcast shares cheap following management comments on Q3 subscriber loses and the resulting stock selloff is overdone.
CMCSK Comcast

04/24/17
OPCO
04/24/17
NO CHANGE
OPCO
Sprint, DISH the only assets for sale, says Oppenheimer
Oppenheimer analyst Timothy Horan noted that wireless companies will be allowed to discuss M&A, and says he sees Sprint (S) and possibly DISH (DISH) as the only assets for sale. The analyst believes the most likely outcome is for consolidation around the four major wireless providers, something along the lines of Charter (CHTR)/Sprint, T-Mobile (TMUS)/Comcast (CMCSA; CMCSK), Verizon (VZ)/DISH, with AT&T's (T) position "fairly solidified" with DirectTV/Time Warner (TWX). Further, Horan suspects Sprint will be sold first, most likely to Charter, although T-Mobile is a possibility and could be the controlling company/management and likely paying a premium for Sprint.
04/20/17
BTIG
04/20/17
NO CHANGE
BTIG
Comcast should try 'hail mary' Charter acquisition, says BTIG
BTIG analyst Rich Greenfield makes the case that Comcast's (CMCSA) "window for M&A is simply to enticing too ignore" and lays out six potential targets that would "truly be transformative," with his top pick among the group being Charter (CHTR). A combination of Charter with Comcast would have "all of the benefits of the legacy Time Warner Cable deal with even more scale" and even though odds of approval are no better than 50/50, it is worth throwing that "hail-mary," Greenfield tells investors. The other five possible deals that Greenfield makes the case for are Disney (DIS), Verizon (VZ), Netflix (NFLX), T-Mobile (TMUS) and Snap Inc.'s (SNAP) Snapchat.
02/03/17
OPCO
02/03/17
NO CHANGE
OPCO
Content/application acquisitions more likely for Verizon, says Oppenheimer
Oppenheimer analyst Timothy Horan says that while he does see a merger with Charter (CHTR) and especially with Comcast (CMCSA) working financially, he believes Verizon (VZ) has its sights set on becoming a platform for digital content/apps monetized with programmatic advertising. This, combined with using wireless technologies to replace wireline broadband, could be "very disruptive to the cable industry," he adds. The analyst sees further acquisitions of content/application companies as more likely for Verizon.
04/26/17
FBCO
04/26/17
NO CHANGE
Target $37
FBCO
Outperform
Hulu stake could be for sale this year, says Credit Suisse
Credit Suisse analyst Omar Sheikh notes that Comcast (CMCSA; CMCSK) will be free to sell its 30% stake in Hulu from the end of 2017. The analyst believes there is a $100B domestic revenue opportunity for targeted TV advertising long-term, which vertically integrated networks/distributors will be in a strong position to exploit. Therefore, Sheikh argues that it would make sense for 21st Century Fox (FOX; FOXA) to acquire Comcast's stake in Hulu, if it becomes available, subject to valuation and appropriate programming supply agreements. He reiterates an Outperform rating and $37 price target on 21st Century Fox's shares.
SNE Sony
$37.50

0.04 (0.11%)

09/19/17
09/19/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Under Armour (UA, UAA) downgraded to Underperform from Market Perform at Wells Fargo with Wells Fargo with analyst Tom Nikic saying with consumers having filled their closets with athletic wear over the past seven years, the category "appears poised to take a breather for now." The analyst cut his price target for the shares to $13 from $17. 2. Kellogg (K) downgraded to Neutral from Overweight at Piper Jaffray with analyst Michael Lavery saying cereal could be at risk from shrinking center store space. 3. Nike (NKE) downgraded to Neutral from Positive at Susquehanna saying that his checks indicate that the North American and European businesses are decelerating as some key categories, especially basketball, have underperformed, resulting in excess inventory that will pressure sales and margins. 4. Synchronoss (SNCR) downgraded to Underperform from Outperform at Raymond James with analyst Tavis McCourt citing the news that Siris Capital is no longer interested in an all-cash transaction for all the outstanding shares of the company and has withdrawn its $18 per share bid from June 22. Further, the analyst believes it increasingly unlikely that the current strategic review will result in an acquisition at a premium and expects share to come under pressure and stay in the range prior to the Siris indication of interest. 5. Sony (SNE) downgraded to Neutral from Outperform at Credit Suisse. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/11/17
SBSH
09/11/17
DOWNGRADE
SBSH
Neutral
Sony downgraded to Neutral from Buy at Citi
Citi analyst Kota Ezawa downgraded Sony to Neutral saying the shares, following the recent rally, are now around fair value. The analyst expects the company's earnings growth to slow.
09/11/17
09/11/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Snap (SNAP) downgraded to Hold from Buy at Deutsche Bank with analyst Lloyd Walmsley saying the risk/reward is more balanced with the shares up 29% since August 11. 2. Owens Corning (OC) downgraded to Neutral from Buy at Nomura Instinet with analyst Michael Wood saying high expectations create a balanced risk/reward at current share levels. 3. Kroger (KR) downgraded to Hold from Buy at Deutsche Bank with analyst Shane Higgins saying the company's sales and earnings growth for the next few years are likely to be below historical averages as it enters a period of increased investment, which warrants a lower multiple. 4. Sony (SNE) downgraded to Neutral from Buy at Citi with analyst Kota Ezawa saying the shares, following the recent rally, are now around fair value. The analyst expects the company's earnings growth to slow. 5. Newell Brands (NWL) downgraded to Hold from Buy at Jefferies with analyst Kevin Grundy citing management's "recent cautionary commentary" on its outlook for the second half of 2018. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/19/17
FBCO
09/19/17
DOWNGRADE
FBCO
Neutral
Sony downgraded to Neutral from Outperform at Credit Suisse
FOX 21st Century Fox
$26.43

0.1 (0.38%)

08/08/17
BNCH
08/08/17
NO CHANGE
BNCH
Buy
Fox-ION 'rumors' most likely a negotiating tactic, says Benchmark
Benchmark analyst Daniel Kurnos highlighted a "slew" of "inconsistencies" that make him skeptical of last week's "unsubstantiated rumor published by Bloomberg" regarding Fox (FOXA) potentially forming a JV with ION and pulling all of its affiliate agreements from Sinclair (SBGI), concluding in a note to investors that this was "just another negotiating tactic by the network." Fox's "cozy" agreements with Tribune (TRCO) may get disrupted by Sinclair's acquisition, added Kurnos, who has a Buy rating on Sinclair shares.
07/25/17
OTRG
07/25/17
DOWNGRADE
OTRG
Mixed
21st Century Fox downgraded to Mixed from Positive at OTR Global
OTR Global downgraded 21st Century Fox to Mixed from Positive
08/01/17
FBCO
08/01/17
NO CHANGE
Target $37
FBCO
Outperform
21st Century Fox, Sky deal to take longer to clear, says Credit Suisse
Credit Suisse analyst Omar Sheikh continues to believe the Sky (SKYAY) transaction will eventually receive full regulatory approval, but highlights there is an elevated risk to the deal if it is referred to the CMA, and at best an extended period before it gets cleared. Meanwhile, he believes the 2018 21st Century Fox (FOXA) organic equity story looks compelling, and reiterates an Outperform rating and $37 price target on the shares.
FOXA 21st Century Fox
$26.88

0.12 (0.45%)

08/11/17
PIPR
08/11/17
INITIATION
Target $35
PIPR
Overweight
21st Century Fox initiated with an Overweight at Piper Jaffray
Piper Jaffray analyst Stan Meyers started 21st Century Fox with an Overweight rating and $35 price target. Fox has some of the best mix of content and remains undervalued relative to peers, the analyst contends.
09/19/17
09/19/17
NO CHANGE

Cowen lowers price targets on media companies
Cowen analyst Doug Crentz cut his price targets for several media companies, as he believes that the margin pressure on TV networks will continue. The analyst believes that consensus estimates for TV broadcasters are too high, as he expects that the decline in the sector's EBITDA margin will more than double this year, driven by lower ad and affiliate revenue. He believes that two "deep-pocketed, low margin competitors -Netflix (NFLX) and Amazon (AMZN) - are the root of the problem. He cut his price target on Viacom (VIAB) to $31 from $41, on Discovery (DISCA) to $19 from $25, on Fox (FOXA) to $29 from $32, on CBS (CBS) to $69 from $70 and on Disney (DIS) to $94 from $95.
09/05/17
WELS
09/05/17
UPGRADE
Target $116
WELS
Outperform
Disney upgraded to Outperform from Market Perform at Wells Fargo
Wells Fargo analyst Marci Ryvicker upgraded Disney (DIS) to Outperform and raised her price target for the shares to $116 from $109. The owner of ESPN and ABC closed Friday up 31c to $101.50. Concerns over potential dilution from the BAMTech stake and the streaming apps are "widely overdone," Ryvicker tells investors in a research note where she also downgraded Viacom (VIAB). She expects the TV ecosystem will soon undergo on an accelerated push into over-the-top. As such, investors may need to start increasing exposure to media companies with solid streaming strategies, such as CBS (CBS), 21st Century Fox (FOXA), and Disney, and lessen exposure to those that do not, such as Viacom and Scripps Networks (SNI)/Discovery Communications (DISCA), Ryvicker argues. The analyst likes the current entry point for Disney shares.
LGF.A Lionsgate
$31.49

0.24 (0.77%)

09/15/17
FBNS
09/15/17
INITIATION
Target $37.71
FBNS
Outperform
Lionsgate initiated with an Outperform at FBN Securities
FBN Securities analyst Robert Routh started Lionsgate with an Outperform rating and $37.71 current fair value estimate, which represents upside of 26.8%. The company has proven it can adapt to an "ever-changing landscape" and recent deals, such as the acquisition of Starz, positions Lionsgate well for "predictable and sustainable" growth moving forward, the analyst contends.
08/30/17
08/30/17
NO CHANGE
Target $35

Overweight
Lionsgate shares remain attractive, says Piper Jaffray
After analyzing the company's film studio, Piper Jaffray analyst Stan Meyers says shares of Lionsgate remain attractive for a "fast growing studio" with expanding margins and solid free cash flow generation. The analyst remains upbeat on the company as Starz transitions into a growth story and it continues to deliver high quality TV content while "systematically assembling a de-risked, diversified film slate." Meyers' base case scenario points to a $35 valuation, which is his price target, $26 in the bear case and $40 in the bull case. He keeps an Overweight rating on Lionsgate.
07/21/17
07/21/17
NO CHANGE

Lionsgate price target raised to $36 from $29 at Loop Capital
Loop Capital analyst David Miller said that while Lionsgate shares have grinded higher as the company "continues to do what it has always done very well," he also has confidence that it is well ahead of plan on Starz synergies and that it has potential from "second-window" sales of streaming rights and orders from OTT platforms. Miller raised his price target on Lionsgate B shares to $36 from $29 and keeps a Buy rating on the name.
09/15/17
09/15/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. DowDuPont (DWDP) initiated with an Overweight at JPMorgan. 2. Lionsgate (LGF.A) initiated with an Outperform at FBN Securities. 3. Sage Therapeutics (SAGE) initiated on huge potential at RBC Capital. 4. Verifone (PAY) initiated with a Neutral at Citi. 5. Oclaro (OCLR) initiated with a Strong Buy at Raymond James. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
DIS Disney
$98.60

-0.29 (-0.29%)

09/05/17
WELS
09/05/17
DOWNGRADE
Target $32
WELS
Market Perform
Viacom downgraded to Market Perform from Outperform at Wells Fargo
Wells Fargo analyst Marci Ryvicker downgraded Viacom (VIAB) to Market Perform and lowered her price target for the shares to $32 from $43. Investors may need to start increasing exposure to media companies with solid streaming strategies given the push into over-the-top, and Viacom does not have one, Ryvicker tells investors in a research note. The analyst does not see much visibility into a turnaround for Viacom's affiliate fee growth. Ryvicker this morning also upgraded Disney (DIS) to Outperform.
09/05/17
09/05/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Disney (DIS) upgraded to Outperform from Market Perform at Wells Fargo with analyst Marci Ryvicker saying concerns over potential dilution from the BAMTech stake and the streaming apps are "widely overdone." 2. Patterson-UTI (PTEN) upgraded to Overweight from Neutral at JPMorgan with analyst Sean Meakim saying the 26% selloff since July 19 has created a buying opportunity. 3. lululemon (LULU) upgraded to Positive from Neutral at Susquehanna with analyst Sam Poser citing improved product mix, momentum carrying into the third quarter and inventory flow to stores that is finally supporting consumer engagement. 4. U.S. Steel (X) upgraded to Buy from Neutral at BofA/Merrill with analyst Timna Tanners saying the U.S. premium to Chinese prices has fallen to just about $75/ton, half the leves he considers "normal" and expects HRC can "surge toward $700/ton by year end. 5. Prologis (PLD) upgraded to Buy from Hold at SunTrust with analyst Ki Bin Kim citing valuation and several positive catalysts. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/19/17
WELS
09/19/17
NO CHANGE
Target $116
WELS
Outperform
Disney streaming could be worth $10-$30 per share, says Wells Fargo
Wells Fargo analyst Marci Ryvicker believes Disney is still "so misunderstood." The analyst argues that the Disney-based streaming could add an incremental $30/share in her highest conviction model and $10/share if she is being ultra-conservative. Ryvicker continues to believe Disney is the best long-term play in the space, and reiterates an Outperform rating and $116 price target on the shares.
VIAB Viacom
$27.64

0.24 (0.88%)

08/04/17
EVER
08/04/17
NO CHANGE
Target $48
EVER
Outperform
Evercore ISI would be a buyer of Viacom near-term weakness at Evercore ISI
Evercore ISI analyst Vijay Jayant would use weakness in Viacom share related to disappointing guidance as a buying opportunity. The analyst believes the company is heading int the right direction under new CEO Bob Bakish, and said there are some early signs that his restructuring plan is working. Jayant rates Viacom an Outperform with a $48 price target.
VIA Viacom
$38.00

-0.2 (-0.52%)

06/15/17
BERN
06/15/17
NO CHANGE
BERN
Viacom shares could tumble to $2.50, says Bernstein
Bernstein analyst Todd Juenger says that Viacom could drop to $2.50 per share if its current $3B EBITDA drops to $2B, and its EBITDA multiple drops to six times. The analyst says that this scenario is "not crazy," since the company's EBITDA fell 33% from fiscal 2014 to fiscal 2016 "during a rip-roaring advertising market and the early days of cord-cutting." He keeps a $29 price target and Underperform rating on the shares.
06/22/17
LOOP
06/22/17
NO CHANGE
Target $37
LOOP
Hold
Viacom unlikely to see boost from 'Transformers' sequel, says Loop Capital
Loop Capital analyst David Miller believes Viacom's "Transformers" franchise is "somewhat long in the tooth" and he sees both the opening weekend and overall domestic grosses for the fifth installment, "The Last Knight" to be muted. He does note, though, that he expects international results to be "quite strong" for the film. Miller keeps a Hold rating on Viacom and lowered his price target to $37 from $39.
07/17/17
JPMS
07/17/17
NO CHANGE
JPMS
Overweight
Viacom shares offer 'great value' at current levels, says JPMorgan
JPMorgan analyst Alexia Quadrani says Viacom over the past few months experienced improving ratings across several of its key networks, which she believes supports a positive outlook for advertising improvement. Shares of Viacom present "great value at these levels," Quadrani tells investors in a research note. She reiterates an Overweight rating on the stock.

TODAY'S FREE FLY STORIES

19:15
10/20/17
10/20
19:15
10/20/17
19:15
General news
Breaking General news story  »

Federal Reserve Chair…

ATRS

Antares Pharma

$2.18

0.06 (2.83%)

18:59
10/20/17
10/20
18:59
10/20/17
18:59
Hot Stocks
FDA cannot approve Antares Pharma's Xyosted NDA »

Antares Pharma announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Oct

18:55
10/20/17
10/20
18:55
10/20/17
18:55
Conference/Events
Federal Reserve Chairperson delivers a lecture at NEC Dinner »

Federal Reserve…

SHIP

Seanergy Marine

$1.24

0.0199 (1.63%)

17:50
10/20/17
10/20
17:50
10/20/17
17:50
Syndicate
Breaking Syndicate news story on Seanergy Marine »

Seanergy Marine files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HLI

Houlihan Lokey

$41.56

0.18 (0.43%)

17:49
10/20/17
10/20
17:49
10/20/17
17:49
Syndicate
Breaking Syndicate news story on Houlihan Lokey »

Houlihan Lokey files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

GEO

Geo Group

$26.20

0.2 (0.77%)

17:48
10/20/17
10/20
17:48
10/20/17
17:48
Syndicate
Breaking Syndicate news story on Geo Group »

Geo Group files automatic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

DBVT

DBV Technologies

$48.07

0.92 (1.95%)

, AIMT

Aimmune

$25.66

-0.06 (-0.23%)

17:37
10/20/17
10/20
17:37
10/20/17
17:37
Hot Stocks
DBV sinks following peanut allergy trial miss, Aimmune soars »

Shares of DBV…

DBVT

DBV Technologies

$48.07

0.92 (1.95%)

AIMT

Aimmune

$25.66

-0.06 (-0.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

KALV

KalVista

$11.26

1.99 (21.47%)

, DBVT

DBV Technologies

$48.07

0.92 (1.95%)

17:24
10/20/17
10/20
17:24
10/20/17
17:24
Hot Stocks
On The Fly: After Hours Movers »

HIGHER: KalVista (KALV),…

KALV

KalVista

$11.26

1.99 (21.47%)

DBVT

DBV Technologies

$48.07

0.92 (1.95%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IPCI

Intellipharmaceutics

17:23
10/20/17
10/20
17:23
10/20/17
17:23
Hot Stocks
Breaking Hot Stocks news story on Intellipharmaceutics »

Armistice Capital reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DBVT

DBV Technologies

$48.07

0.92 (1.95%)

17:21
10/20/17
10/20
17:21
10/20/17
17:21
Hot Stocks
DBV Technologies: PEPITES trial does not reach primary endpoint »

DBV Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WFC

Wells Fargo

$54.92

1.17 (2.18%)

17:08
10/20/17
10/20
17:08
10/20/17
17:08
Periodicals
Regulator criticizes Wells Fargo over deceptive auto insurance program, NYT says »

The Office of the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 02

    Nov

  • 07

    Nov

  • 29

    Nov

  • 15

    Jan

ALIM

Alimera Sciences

17:01
10/20/17
10/20
17:01
10/20/17
17:01
Syndicate
Alimera Sciences to sell $25M in shares in an 'at the market offering' »

On October 20, Alimera…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SYMC

Symantec

$32.66

0.33 (1.02%)

16:51
10/20/17
10/20
16:51
10/20/17
16:51
Syndicate
Breaking Syndicate news story on Symantec »

Symantec files to sell 1M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

EBMT

Eagle Bancorp

$19.55

0.15 (0.77%)

16:44
10/20/17
10/20
16:44
10/20/17
16:44
Hot Stocks
Breaking Hot Stocks news story on Eagle Bancorp »

EJF Capital reports 7%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KALV

KalVista

$11.26

1.99 (21.47%)

16:43
10/20/17
10/20
16:43
10/20/17
16:43
Hot Stocks
Breaking Hot Stocks news story on KalVista »

Longwood Fund II reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JAGX

Jaguar Health

$0.19

0.002 (1.08%)

16:41
10/20/17
10/20
16:41
10/20/17
16:41
Syndicate
Breaking Syndicate news story on Jaguar Health »

Jaguar Health files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSLA

Tesla

$345.10

-6.71 (-1.91%)

16:40
10/20/17
10/20
16:40
10/20/17
16:40
Hot Stocks
Tesla amends 'warehouse agreements' to increase commitments to $1.1B »

On October 18,Tesla…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

  • 06

    Nov

SNV

Synovus

$47.30

0.54 (1.15%)

16:38
10/20/17
10/20
16:38
10/20/17
16:38
Hot Stocks
Synovus CBO sells 10,000 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Nov

  • 15

    Nov

GTXI

GTx

$7.92

0.1 (1.28%)

16:38
10/20/17
10/20
16:38
10/20/17
16:38
Syndicate
Breaking Syndicate news story on GTx »

GTx files to sell 8.77M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ASB

Associated Banc-Corp

$25.90

1.3 (5.28%)

, BKMU

BankMutual

$10.80

0.55 (5.37%)

16:36
10/20/17
10/20
16:36
10/20/17
16:36
Conference/Events
BankMutual to host special shareholder meeting »

Special Shareholder…

ASB

Associated Banc-Corp

$25.90

1.3 (5.28%)

BKMU

BankMutual

$10.80

0.55 (5.37%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

CNXR

Connecture

$0.49

-0.01 (-2.00%)

16:35
10/20/17
10/20
16:35
10/20/17
16:35
Hot Stocks
Breaking Hot Stocks news story on Connecture »

Connecture trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GE

General Electric

$23.83

0.25 (1.06%)

, PG

Procter & Gamble

$88.25

-3.34 (-3.65%)

16:31
10/20/17
10/20
16:31
10/20/17
16:31
General news
On The Fly: Top stock stories for Friday »

Stocks opened sharply…

GE

General Electric

$23.83

0.25 (1.06%)

PG

Procter & Gamble

$88.25

-3.34 (-3.65%)

CELG

Celgene

$121.33

-14.63 (-10.76%)

SNCR

Synchronoss

$11.39

-0.12 (-1.04%)

IL

Bought by SNCR

SKX

Skechers

$33.99

9.96 (41.45%)

PYPL

PayPal

$70.97

3.72 (5.53%)

NCR

NCR Corp.

$33.05

-4 (-10.80%)

LHO

LaSalle Hotel

$28.52

-1.94 (-6.37%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Oct

  • 20

    Oct

  • 20

    Oct

  • 20

    Oct

  • 22

    Oct

  • 26

    Oct

  • 28

    Oct

  • 06

    Nov

  • 08

    Nov

  • 08

    Nov

  • 29

    Nov

  • 30

    Nov

16:30
10/20/17
10/20
16:30
10/20/17
16:30
Options
Preliminary option volume of 22.9M today »

Preliminary option volume…

MKL

Markel

$1,078.23

14.88 (1.40%)

, SNC

State National

$21.05

0.02 (0.10%)

16:26
10/20/17
10/20
16:26
10/20/17
16:26
Conference/Events
State National to host special shareholder meeting »

Special Shareholder…

MKL

Markel

$1,078.23

14.88 (1.40%)

SNC

State National

$21.05

0.02 (0.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 26

    Oct

RYTM

Rhythm Pharmaceuticals

$23.08

-0.17 (-0.73%)

16:22
10/20/17
10/20
16:22
10/20/17
16:22
Hot Stocks
Breaking Hot Stocks news story on Rhythm Pharmaceuticals »

Orbimed Advisors reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.